Clinical Trials Directory

Trials / Completed

CompletedNCT02192983

A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.

A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
242 (actual)
Sponsor
Tianshu Liu · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.

Conditions

Timeline

Start date
2008-11-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-07-17
Last updated
2015-12-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02192983. Inclusion in this directory is not an endorsement.

A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer. (NCT02192983) · Clinical Trials Directory